Literature DB >> 23579236

Complete genome sequence analysis of novel human bocavirus reveals genetic recombination between human bocavirus 2 and human bocavirus 4.

Pattara Khamrin1, Shoko Okitsu, Hiroshi Ushijima, Niwat Maneekarn.   

Abstract

Epidemiological surveillance of human bocavirus (HBoV) was conducted on fecal specimens collected from hospitalized children with diarrhea in Chiang Mai, Thailand in 2011. By partial sequence analysis of VP1 gene, an unusual strain of HBoV (CMH-S011-11), was initially identified as HBoV4. The complete genome sequence of CMH-S011-11 was performed and analyzed further to clarify whether it was a recombinant strain or a new HBoV variant. Analysis of complete genome sequence revealed that the coding sequence starting from NS1, NP1 to VP1/VP2 was 4795 nucleotides long. Interestingly, the nucleotide sequence of NS1 gene of CMH-S011-11 was most closely related to the HBoV2 reference strains detected in Pakistan, which contradicted to the initial genotyping result of the partial VP1 region in the previous study. In addition, comparison of NP1 nucleotide sequence of CMH-S011-11 with those of other HBoV1-4 reference strains also revealed a high level of sequence identity with HBoV2. On the other hand, nucleotide sequence of VP1/VP2 gene of CMH-S011-11 was most closely related to those of HBoV4 reference strains detected in Nigeria. The overall full-length sequence analysis revealed that this CMH-S011-11 was grouped within HBoV4 species, but located in a separate branch from other HBoV4 prototype strains. Recombination analysis revealed that CMH-S011-11 was the result of recombination between HBoV2 and HBoV4 strains with the break point located near the start codon of VP2.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23579236     DOI: 10.1016/j.meegid.2013.03.040

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  7 in total

Review 1.  Human Parvoviruses.

Authors:  Jianming Qiu; Maria Söderlund-Venermo; Neal S Young
Journal:  Clin Microbiol Rev       Date:  2017-01       Impact factor: 26.132

2.  Whole-genome sequencing analysis of human bocavirus detected in South Korea.

Authors:  L H Kang; Y J Won; A R Lee; S G Lee; H G Cho; Y J Park; J I Han; S Y Paik
Journal:  Epidemiol Infect       Date:  2018-03-14       Impact factor: 4.434

3.  Description of a human Bocavirus recombinant strain in the Americas.

Authors:  Matías Salvo; Daiana Mir; Luis Fernando López Tort; Andrés Lizasoain; Rodney Colina; Matías Victoria
Journal:  Mem Inst Oswaldo Cruz       Date:  2019-10-21       Impact factor: 2.743

4.  Equine Parvovirus-Hepatitis in China: Characterization of Its Genetic Diversity and Evidence for Natural Recombination Events Between the Chinese and American Strains.

Authors:  Gang Lu; Liyan Wu; Jiajun Ou; Shoujun Li
Journal:  Front Vet Sci       Date:  2020-03-10

5.  Genetic Diversity and Phylogenetic Analysis of Human Bocavirus 2 in Pediatric Patients with Acute Gastroenteritis in Taiwan.

Authors:  Marco Yung-Cheng Lin; Hsiu-Chuan Chan; Hsin Chi; Shu-Chun Chiu; Zaiga Nora-Krukle; Santa Rasa-Dzelzkaleja; Anda Vilmane; Modra Murovska; Jih-Hui Lin; Hsin-Fu Liu
Journal:  Int J Environ Res Public Health       Date:  2020-02-08       Impact factor: 3.390

6.  Prevalence and Molecular Characterization of Human Bocavirus Detected in Croatian Children with Respiratory Infection.

Authors:  Sunčanica Ljubin-Sternak; Anamarija Slović; Maja Mijač; Mirna Jurković; Dubravko Forčić; Irena Ivković-Jureković; Tatjana Tot; Jasmina Vraneš
Journal:  Viruses       Date:  2021-08-31       Impact factor: 5.048

7.  Identification of Human Bocavirus type 4 in a child asymptomatic for respiratory tract infection and acute gastroenteritis - Goiânia, Goiás, Brazil.

Authors:  Teresinha Teixeira de Sousa; Tâmera Nunes Vieira Almeida; Fabíola Souza Fiaccadori; Menira Souza; Kareem Rady Badr; Divina das Dôres de Paula Cardoso
Journal:  Braz J Infect Dis       Date:  2017-05-10       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.